Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-22T05:08:28.108Z Has data issue: false hasContentIssue false
  • English
  • Français

Underusage of radiotherapy and a lack of socio-economic disparity in treatment outcome: a population-based study on adenoid cystic carcinomas

Published online by Cambridge University Press:  17 May 2013

Rex Cheung
Rex Cheung*
Affiliation:
275 S Bryn Mawr Ave, K43, Bryn Mawr, PA 19010
*
Correspondence to: Rex Cheung, 275 S Bryn Mawr Avenue, K43, Bryn Mawr, PA 19010, USA. Tel: 215 287 2501. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

This study used receiver operating characteristic curve to analyse a long list of biological, treatment and socio-economic predictors of adenoid cystic carcinoma treatment outcome. Anatomical staging was found to be the most predictive factor of outcome.

Purpose

This study used receiver operating characteristic curve (ROC) to analyse surveillance, epidemiology and end results (SEER) adenoid cystic carcinoma data to identify predictive models and potential disparity in outcome.

Materials and methods

For the risk modelling, each factor was fitted by a generalised linear model to predict the cause-specific survival. The area under the ROC was computed. Similar strata were combined to construct the most parsimonious models. A random sampling algorithm was used to estimate the modelling errors. Risk of adenoid cystic carcinoma death was computed for the predictors for comparison.

Results

There were 5,947 patients diagnosed from 1973 to 2009 included in this study. The mean follow-up time (SD) was 93·8 (90·6) months. Three out of five patients were women. The mean (SD) age was 58·55 (16·01) years. SEER stage was the most predictive factor of outcome (ROC area of 0·68). Sex, radiotherapy and surgery had ROC areas of about 0·57. None of the socio-economic disparities was found for treatment outcome. Radiotherapy was underused in localised and regional stages when the intent was curative, especially in older patients.

Conclusion

Anatomical staging was predictive and useful in treatment selection. Understaging and underuse of radiotherapy may have contributed to poor outcomes.

Keywords

adenoid cystic carcinomacause specific survivalradiotherapySEER registryunder usage
Type
Original Articles
Information
Journal of Radiotherapy in Practice , Volume 13 , Issue 2 , June 2014 , pp. 203 - 210
Copyright
Copyright © Cambridge University Press 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Ellington, C L, Goodman, M, Kono, S Aet al. Adenoid cystic carcinoma of the head and neck: incidence and survival trends based on 1973–2007 Surveillance, Epidemiology, and End Results data. Cancer 2012; 118 (21): 1448–1449.Google Scholar
2.Ghabach, B, Anderson, W F, Curtis, R Eet al. Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort study. Breast Cancer Res 2010; 12: R54.CrossRefGoogle ScholarPubMed
3.Bhattacharyya, N, Fried, M P. Determinants of survival in parotid gland carcinoma: a population-based study. Am J Otolaryngol 2005; 26: 39–44.CrossRefGoogle ScholarPubMed
4.Lloyd, S, Yu, J B, Wilson, L D, Decker, R H. Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy. Am J Clin Oncol 2011; 34: 76–81.Google Scholar
5.Kakarala, K, Bhattacharyya, N. Survival in oral cavity minor salivary gland carcinoma. Otolaryngol Head Neck Surg 2010; 143: 122–126.Google Scholar
6.Lloyd, S, Yu, J B, Ross, D A, Wilson, L D, Decker, R H. A prognostic index for predicting lymph node metastasis in minor salivary gland cancer. Int J Radiat Oncol Biol Phys 2010; 76: 169–175.Google Scholar
7.Boukheris, H, Curtis, R E, Land, C E, Dores, G M. Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States. Cancer Epidemiol Biomarkers Prev 2009; 18: 2899–2906.Google Scholar
8.Shindo, M, Aoki, S, Ikeda, E. [Adenoid cystic carcinoma of the prostate. A case report]. Nippon Hinyokika Gakkai Zasshi–Japanese Journal of Urology 1998; 89: 670–673.Google Scholar
9.Li, N, Xu, L, Zhao, H, El-Naggar, A K, Sturgis, E M. A comparison of the demographics, clinical features, and survival of patients with adenoid cystic carcinoma of major and minor salivary glands versus less common sites within the Surveillance, Epidemiology, and End Results registry. Cancer 2012; 118: 3945–3953.CrossRefGoogle ScholarPubMed
10.Perez, E A, Kassira, N, Cheung, M Cet al. Rhabdomyosarcoma in children: a SEER population based study. J Surg Res 2011; 170: e243–e251.Google Scholar
11.Bhatia, S. Disparities in cancer outcomes: lessons learned from children with cancer. Pediatr Blood Cancer 2011; 56: 994–1002.Google Scholar
12.Pappo, A S, Krailo, M, Chen, Z, Rodriguez-Galindo, C, Reaman, G. Infrequent tumor initiative of the Children's Oncology Group: initial lessons learned and their impact on future plans. J Clin Oncol 2010; 28: 5011–5016.CrossRefGoogle ScholarPubMed
13.Cheung, M C, Zhuge, Y, Yang, Ret al. Incidence and outcomes of extremity soft-tissue sarcomas in children. J Surg Res 2010; 163: 282–289.Google Scholar
14.McDowell, H P, Foot, A B, Ellershaw, Cet al. Outcomes in paediatric metastatic rhabdomyosarcoma: results of The International Society of Paediatric Oncology (SIOP) study MMT-98. Eur J Cancer 2010; 46: 1588–1595.Google Scholar
15.Ognjanovic, S, Linabery, A M, Charbonneau, B, Ross, J A. Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975-2005. Cancer 2009; 115: 4218–4226.Google Scholar
16.Sultan, I, Qaddoumi, I, Yaser, S, Rodriguez-Galindo, C, Ferrari, A. Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients. J Clin Oncol 2009; 27: 3391–3397.Google Scholar
17.Polednak, A P. Trends in incidence rates of tobacco-related cancer, selected areas, SEER Program, United States, 1992-2004. Prev Chronic Dis 2009; 6: A16.Google Scholar
18.Cheung, R. Poor treatment outcome of neuroblastoma and other peripheral nerve cell tumors may be related to under usage of radiotherapy and socio-economic disparity: a US SEER data analysis. Asian Pac J Cancer Prev 2012; 13: 4587–4591.Google Scholar
19.Cheung, R, Altschuler, M D, D'Amico, A Vet al. ROC-optimization may improve risk stratification of prostate cancer patients. Urology 2001; 57: 286–290.CrossRefGoogle ScholarPubMed
20.Cheung, R, Altschuler, M D, D'Amico, A Vet al. Using the receiver operator characteristic curve to select pretreatment and pathologic predictors for early and late post-prostatectomy PSA failure. Urology 2001; 58: 400–405.Google Scholar
21.Hanley, J A, McNeil, B J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29–36.CrossRefGoogle Scholar
22.D'Amico, A V, Desjardin, A, Chung, Aet al. Assessment of outcome prediction models for patients with localized prostate carcinoma managed with radical prostatectomy or external beam radiation therapy. Cancer 1998; 82: 1887–1896.Google Scholar
23.Kuhlthau, K A, Pulsifer, M B, Yeap, B Yet al. Prospective study of health-related quality of life for children with brain tumors treated with proton radiotherapy. J Clin Oncol 2012; 30: 2079–2086.Google Scholar
24.DeLaney, T F. Clinical proton radiation therapy research at the Francis H. Burr Proton Therapy Center. Technol Cancer Res Treat 2007; 6: 61–66.Google Scholar
25.Cohen, R J, Curtis, R E, Inskip, P D, Fraumeni, J F Jr. The risk of developing second cancers among survivors of childhood soft tissue sarcoma. Cancer 2005; 103: 2391–2396.CrossRefGoogle ScholarPubMed
26.Miralbell, R, Lomax, A, Cella, L, Schneider, U. Potential reduction of the incidence of radiation-induced second cancers by using proton beams in the treatment of pediatric tumors. Int J Radiat Oncol Biol Phys 2002; 54: 824–829.CrossRefGoogle ScholarPubMed